Box | Folder
|
Title
|
|
Hypertension [H],
1939-96 [subseries]:
|
|
Saluretic Agents [H-1],
1953-91 [subseries]:
|
12 |
2-3 |
Chlorothiazide - Mechanism of action [34.1],
1957-89
|
12 |
4 |
Thiazide - Effects on LVH [34.2],
1982-87
|
12 |
5 |
Thiazide drugs [32],
1958-69, 1984
|
12 |
6 |
Mercurials [31],
[after 1985]
|
12 |
7 |
Thiazides' effect on calcium [30],
1990-91
|
12 |
8 |
Aldosterone antagonists [29],
1953-80
|
12 |
9 |
Polythiazide [28],
1961-63
|
12 |
10 |
Non saluretic thiazides [27],
1961-68
|
12 |
11 |
Triamterene and MK870 [26],
1961-85
|
12 |
12 |
Furosemide [25],
1964-79
|
12 |
13 |
Ticrynafen [24],
1978-80
|
|
Blocking Agents [H-2],
1946-96 [subseries]:
|
12 |
14 |
Hexamethonium - Pharmacology [34A],
1950-60
|
12 |
15 |
Hexamethonium - Treatment, Clinical [34B],
1950-56
|
12 |
16 |
Hexamethonium and Hydralazine [34C],
1952-55
|
12 |
17 |
Hexamethonium and Rauwolfia [34D],
1953
|
12 |
18 |
Hexamethonium - Correspondence and reports [34E],
1951-64
|
12 |
19 |
Pentolinium - Pharmacology [33A],
1956-60
|
12 |
20 |
Pentolinium - Clinical [33B],
1953-56
|
12 |
21 |
Pentolinium - with Hydralazine [33C],
1955
|
12 |
22 |
Pentolinium - with Rauwolfia [33D],
1954-55
|
12 |
23 |
Pentolinium - Correspondence and reports [33E],
1954-55
|
12 |
24 |
Chlorisondamine - Pharmacology [32A],
1954-58
|
12 |
25 |
Chlorisondamine - Treatment [32B],
1955-57
|
12 |
26 |
Chlorisondamine - Correspondence and reports [32C],
1954-56
|
12 |
27 |
Mecamylamine [31],
1955-60
|
12 |
28 |
Miscellaneous blocking drugs - Arfonad [30],
1946-61
|
12 |
29 |
Ganglion blocking agents - Trimethidinium methosulfate [30],
1958-62
|
12 |
30 |
Pempidine [30],
1960
|
12 |
31-32 |
Guanethidine [29],
1959-76
|
12 |
33 |
Darenthin (or Bretylium) [28],
1959-62
|
12 |
34 |
Iproniazid and Catron [27],
1959-63
|
12 |
35 |
Pargyline [26],
1961-64
|
12 |
36 |
Ganglion blocking agents - Literature, side effects, toxicity, tolerance [25],
1948-63
|
12 |
37 |
Ganglion blocking agents - General chemical and pharmacological [25],
1947-63
|
12 |
38 |
Ganglion blocking agents - Clinical uses other than in hypertension [25],
1948-56
|
12 |
39 |
Sympatholytic, selective [23],
1960-66
|
12 |
40 |
General [22],
1948-74
|
12 |
41 |
Phentolamine (Regitine) [21],
1965
|
12 |
42-43 |
Adrenergic blockers - Various (includes Labetalol) [19],
1949-85
|
12 |
44 |
Aldomet [18],
1961-88
|
12 |
45-47 |
Beta adrenergic blockers [17],
1966-96
|
12 |
48-49 |
Propranolol [16],
1966-83
|
12 |
50 |
Angiotensin blockers - including Saralasin [15],
1984-95
|
12 |
51 |
Angiotensin blockers - Enalapril 421 or 521 [15A],
1978-90
|
12 |
52 |
Losartan [15B],
1992-95
|
13 |
1 |
Clonidine [14],
1975-85
|
13 |
2 |
Guanabenz [13],
1981-83
|
13 |
3 |
Thiocyanate [12],
[after 1970]
|
13 |
4 |
Calcium Channel Block [7],
1995
|
13 |
|
Etiology and Pathogenesis [H-3],
1948-95 [subseries]:
|
13 |
5-6 |
Renin - Renal pressor theory [34],
1959-90
|
13 |
7 |
Kidney in [hypertension] - Pyelonephritis [33],
1959-70
|
13 |
8 |
Unilateral renal vascular disease [32],
1956-87
|
13 |
9 |
Renoprival [31],
1951-65
|
13 |
10 |
Renal, other [30],
1955-86
|
13 |
11-12 |
Salt in hypertension [29],
1955-87
|
13 |
13-14 |
K+ in diet and Na/K+ Ratio. Also, calcium [29A],
1975-88
|
13 |
15 |
Salt sensitivity - Potassium [29B],
1972-95
|
13 |
16 |
Neural [28],
1975-94
|
13 |
17 |
Baroreceptor theories [27],
1948-91
|
13 |
18 |
Sympathetic nerves [26],
1949-83
|
13 |
19 |
Brain and post, pituitary [25],
1958-88
|
13 |
20-21 |
Emotional stress - Neurogenic, other [ 24],
1950-86
|
13 |
22 |
Adrenal cortex [23],
1949-91
|
13 |
23 |
Hormonal, adrenal medulla [22],
1961-88
|
13 |
24 |
Pituitary in [hypertension] [21],
1948-50
|
13 |
25 |
Hormonal, other [20],
1955-82
|
13 |
26 |
Coarctation of aorta [19],
1951-88
|
13 |
27 |
Hypertension and heredity [18],
1953-87
|
13 |
28 |
Environment [17],
1957-77
|
13 |
29 |
Ca, Mg [16],
1985
|
13 |
30-31 |
Other ions than Na+ - Mg++, Ca++, K+, Cl [15],
1961-94
|
13 |
32-33 |
Fluid volumes in [hypertension] [14],
1952-93
|
13 |
34-38 |
Epidemiological studies [13],
1953-91
|
13 |
39-40 |
Epidemiology - Racial differences [13A],
1956-75
|
13 |
41 |
Exaggerated natriuresis in [hypertension] [12],
1949-62
|
13 |
42 |
Toxemia of pregnancy [11],
1964-84
|
13 |
43 |
Cardiogenic [10],
1962-84
|
14 |
1 |
Miscellaneous [9],
1962-87
|
14 |
2 |
History of hypertension [8] [photograph],
[ca. 1960-64]
|
14 |
3 |
Reviews, general [7],
1976-80
|
14 |
4 |
Kallikrein and prostaglandins [6],
1968-85
|
14 |
5 |
Fast-twitch muscle fibers in hypertension - lower body compression [5],
1979-84
|
14 |
6 |
Atrial natriuretic factor [4],
1984-90
|
14 |
7 |
Insulin resistance diabetes [3],
1986-91
|
14 |
8 |
Obesity [3 - crossed out in index],
1987
|
14 |
9 |
Endothelium relaxing factor, etc. [2],
1989
|
|
Other Antihypertensive Agents, General Treatment Control Studies [H-4],
1940-96 [subseries]:
|
14 |
10 |
Hydralazine - Literature - Clinical [34],
1951-83
|
14 |
11 |
Hydralazine - Literature - Pharmacology [34],
1951-81
|
14 |
12 |
Hydralazine - Literature - Toxicity [34],
1953-82
|
14 |
13 |
Hydralazine - like agents [33],
1945-49
|
14 |
14 |
Rauwolfia - Side effects [32],
1954-83
|
14 |
15 |
Rauwolfia - Crude root [31],
1955-63
|
14 |
16 |
Reserpine - Pharmacology [29],
1954-77
|
14 |
17 |
Reserpine - Antiarrhythmic activity [29],
1955-66
|
14 |
18-19 |
Rauwolfia - Reserpine - Treatment [29],
1954-84
|
14 |
20 |
Rauwolfia - Various alkaloids [28],
1955-65
|
14 |
21 |
Veratrum - Pharmacology [27],
1949-66, 1983
|
14 |
22 |
Veratrum - Viride - Clinical treatment [26],
1948-54
|
14 |
23 |
Control studies [25],
1960-79, 1996
|
14 |
24 |
Veratrum - Other alkaloids - Protoveratrine, etc., Viscum album [24],
1949-59
|
14 |
25 |
Veratrum - Neogermitrine assay data [24],
1950
|
14 |
26 |
Sympathectomy [21],
1940-61
|
14 |
27 |
Miscellaneous [20],
1948-69
|
14 |
28 |
Azide Sodium - Literature [20],
1954-61
|
14 |
29 |
Hypertensive agent IN-66 (Irwin, Neisler and Co.) [20] [Restricted],
1952-1953
|
14 |
30 |
Adrenalectomy [19],
1951-54
|
14 |
31-34 |
Treatment Dietary [18],
1948-57, 1973-91
|
14 |
35 |
Surgery of renal hypertension [17],
1963
|
14 |
36 |
Renal transplants [16],
1964-65
|
14 |
37 |
Diazoxide [15],
1976
|
14 |
38 |
General discussion and review [14],
1974-81
|
14 |
39-40 |
Prazosin [13],
1974-95
|
14 |
41 |
Minoxidil [12],
1973-81
|
14 |
42 |
Cost of drugs [11],
1978-83
|
14 |
43-46 |
FDA and drug regulations [10],
1971-83
|
15 |
1 |
Psychophysiological techniques [9],
1972-84
|
15 |
2 |
National programs [8],
1977-82
|
15 |
3 |
Calcium antagonists - General [7A],
1977-92
|
15 |
4 |
Calcium antagonists - Nitrendipine [7C],
[1984-85]
|
15 |
5 |
Calcium antagonists - Diltiazem [7D],
1982-89
|
15 |
6 |
Verapramil [7E],
1982-87
|
15 |
7 |
Exercise [6],
1978-86
|
15 |
8 |
Reverse titration [5],
1967-82
|
15 |
9 |
Serotonin antagonists [4],
1984-86
|
|
Clinical [H-5],
1943-93 [subseries]:
|
15 |
10 |
General discussion of disease - Reviews [34],
1946-50, 1970
|
15 |
11 |
Subarachnoid hemorrhage [33],
1982
|
15 |
12 |
Left Ventricular Hypertrophy / ECG or VCG in Hypertension [32],
1962-97
|
15 |
13 |
Prognosis, untreated [31],
1943-74
|
15 |
14 |
Treatment effect on prognosis - Indications for Rx mild [30],
1956-88
|
15 |
15 |
Prognosis with surgical [29],
1950-62
|
15 |
16 |
Reactivity in borderline hypertension [28],
1955-90
|
15 |
17 |
Practical details of drug treatment, home BPs, cost, etc. [27],
1974-88
|
15 |
18 |
Antihypertensive Drugs - Treatment, general [26],
1959-93
|
15 |
19 |
Systolic hypertension [25],
1982-88
|
15 |
20 |
Effects of Rx on organic damage (Cardiac, renal) [24] [photograph],
1951-91
|
15 |
21-22 |
Blood pressure recording [23],
1954-90
|
15 |
23 |
Blood pressure - Casual versus basal [22],
1953-89
|
15 |
24 |
Ambulatory BP monitoring [22A],
1981-90
|
15 |
25 |
Miscellaneous symptoms (Headache, etc.) [21],
1962, 1986-88
|
15 |
26 |
Uric acid, gout, gouty nephritis [20],
1963, 1966
|
15 |
27 |
Hypertensive encephalopathy and crisis [19],
1975-92
|
15 |
28 |
Dissecting aneurysm [18],
1968-82
|
15 |
29-30 |
Clinics for hypertension - Detection, costs [17],
1972-98
|
15 |
31 |
Hypertension in children [16],
1960-88
|
15 |
32 |
Physician education - Tests, nurse education, etc. [15],
1959-79
|
15 |
33 |
Hypertension in the aged [14],
1970-92
|
15 |
34-35 |
Obesity - Weight reduction [13],
1967-92
|
15 |
36 |
Comments on trials [12A],
1974-90
|
15 |
37-38 |
Compliance [11],
1967-87
|
15 |
39 |
Blacks and other race [10],
1976-89
|
15 |
40 |
Low lipid diets [9],
1981-87
|
15 |
41 |
Mental and behavioral [with and without] Rx [8],
1971-89
|
15 |
42 |
Stepdown of Rx [7],
1956, 1975-89
|
15 |
43 |
Left Ventricular Hypertrophy [6],
1979-94
|
15 |
44 |
The J curve [5],
1985-91
|
15 |
45 |
Circadian rhythm [4],
1992
|
15 |
46 |
Kidney in hypertension [3],
1988-92
|
15 |
47 |
Diabetes and HBP - Nephropathy [2],
1989-93
|
|
Atherosclerosis [H-6],
1949-93 [subseries]:
|
15 |
48 |
Atherosclerosis - Cholesterol in [34],
1957-89
|
15 |
49 |
Atherosclerosis and L[ow]-D[ensity] L[ipoproteins] [33],
1982
|
15 |
50 |
Atherosclerosis and dietary fat [32],
1955-90
|
15 |
51 |
Physical activity [31],
1960, 1981-87
|
15 |
52 |
Coronary [30],
1963-82
|
16 |
1 |
Lipids other than cholesterol [29],
1949-59, 1982
|
16 |
2 |
MER 29 - Cholesterol synthesis antagonists [28],
1960-62
|
16 |
3 |
Thyroid substances [27],
1949-57
|
16 |
4 |
Vessel wall factors [26],
1958-93
|
16 |
5-6 |
Miscellaneous drug treatment [25],
1957-91
|
16 |
7 |
Reviews [24],
1976-89
|
16 |
8-10 |
Epidemiology of coronary artery disease [23] [photographs],
[1967]-88
|
16 |
11 |
By-pass surgery [22],
1977-90
|
16 |
12 |
Apolipoproteins [21],
1986
|
16 |
13 |
Blood clotting factors and prevention of M[yocardial] I[nfarction] [21],
1980-82
|
16 |
14 |
H[igh]-D[ensity] L[ipoprotein] [20],
1980-91
|
16 |
15 |
C[oronary] H[eart] D[isease] mortality - secondary prevention trials [19],
1984
|
16 |
16 |
Exercise [18],
1982-84
|
16 |
17 |
Acute Miyocardial] I[nfarction] [17],
1988-91
|
16 |
18 |
Hypertension and accelerated atherosclerosis [16] [photograph],
1960-82
|
16 |
19 |
Primary prevention control trials [15],
1984-91
|
16 |
20 |
Treatment of coronary occlusion with anticoagulants [14],
1985-90
|
16 |
21 |
Angina [13],
1984
|
16 |
22 |
Smoking [11],
1991
|
|
Organ Systems In and Types of Hypertension [H-7],
1939-89 [subseries]:
|
16 |
23 |
Malignant - Untreated [34],
1939, 1948-79
|
16 |
24 |
Malignant - Treated [33] [photographs],
1953-67
|
16 |
25 |
General [32],
1961
|
16 |
26 |
Kidney in [31],
1941-78
|
16 |
27 |
Heart in [30],
1958-89
|
16 |
28-29 |
Brain in [29],
1945-88
|
16 |
30 |
Large vessels in [28],
1955-88
|
16 |
31-32 |
Small vessels in [27],
1956-89
|
16 |
33 |
Other organs in [26],
1952-60
|
16 |
34-35 |
Pheochromocytoma [25],
1954-85
|
16 |
36 |
Fundi [24],
1962, 1980-85
|
16 |
37 |
Adrenal cortex in [23],
1941-75
|
16 |
38 |
Atherosclerosis in [22],
1959-87
|
16 |
39 |
Classification [21],
1946-58
|
16 |
40 |
S[pontaneously] H[ypertensive] R[at] [20],
1956-81
|
16 |
41 |
Veins - Venous tone [19],
1978-87
|
16 |
42 |
Vascular endothelium [18],
[ca. 1980-89]
|